The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters

By Gao Rui-juan  

Breast Cancer Research and Treatment, Vol. 93, Iss. 2, 2005-09 ,pp. : 111-115

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of the Prognostic Relevance of Serum Anti-p53 Antibodies in Epithelial Ovarian Cancer

By Gadducci A.   Ferdeghini M.   Buttitta F.   Cosio S.   Fanucchi A.   Annicchiarico C.   Gagetti O.   Bevilacqua G.   Genazzani A.R.  

Gynecologic Oncology, Vol. 72, Iss. 1, 1999-01 ,pp. : 76-81

Elsevier

Access to resources Recommend Favorite

Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients

By Kulić A.   Sirotković-Skerlev M.   Jelisavac-Ćosić S.   Herceg D.   Kovač Z.   Vrbanec D.  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 887-893

Humana Press, Inc

Access to resources Recommend Favorite

p53 Allelotypes and Enhanced Detection of Allelic Loss in Ovarian Cancer: Lack of Correlation with Familial and Clinical Factors

By Skilling J.S.   Powills K.   Lager D.J.   Anderson B.   Sorosky J.   Buller R.E.  

Gynecologic Oncology, Vol. 61, Iss. 2, 1996-05 ,pp. : 180-188

Academic Press

Access to resources Recommend Favorite

Detection of the TP53 Tumour Suppressor Gene Product and p53 Auto-antibodies in the Ascites of Women with Ovarian Cancer

By Angelopoulou K.   Diamandis E.P.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite